Digoxin: Immunologic Approaches to Measurement and Reversal of Toxicity
- 19 November 1970
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 283 (21), 1150-1156
- https://doi.org/10.1056/nejm197011192832109
Abstract
THE clinical use of digitalis is accompanied by a distressingly high prevalence of toxic manifestations, the most serious of which are arrhythmias and disturbances of conduction.1 , 2 Many factors contribute to the development of digitalis toxicity (Table 1). Perhaps the most important is the accumulation of excessive amounts of digitalis in the body and in the myocardium in particular.Although excessive digitalis accumulation occasionally reflects excessive dosage, it is more commonly due to diminished excretion. Largely as a result of the studies of Doherty3 4 5 6 7 and of Marcus8 9 10 and their collaborators, much has recently been learned about the factors that lead to . . .Keywords
This publication has 29 references indexed in Scilit:
- Binding of digitoxin and some related cardenolides to human plasma proteinsJournal of Clinical Investigation, 1969
- Digoxin Metabolism in the ElderlyCirculation, 1969
- The Clinical Pharmacology of Digitalis GlycosidesThe American Journal of the Medical Sciences, 1968
- Tritiated Digoxin Excretion of Patients Following Renal TransplantationCirculation, 1968
- The Distribution and Concentration of Tritiated Digoxin in Human TissuesAnnals of Internal Medicine, 1967
- Administration of Tritiated Digoxin with and without a Loading DoseCirculation, 1966
- Digitalis-induced arrhythmias and their managementProgress in Cardiovascular Diseases, 1966
- Digoxin Metabolism in Hypo- and HyperthyroidismAnnals of Internal Medicine, 1966
- Diagnosis and Treatment of Digitalis ToxicityNew England Journal of Medicine, 1965
- Tritiated Digoxin Studies in Human SubjectsArchives of Internal Medicine, 1961